Latest News
SF Holding Reports Solid First Half 2026 Results, Accelerating International Growth and Enhancing Shareholder Returns
* Supply Chain and International revenue increased 15.6% year-over-year, and excluding KLN the revenue surged by 46.6%, as the Company's second growth engine accelerated * Adjusted net profit increased to RMB 5.0 billion, up 9.3% year-over-year, underpinned by continuous operational optimisat...
2026-08-28 22:27
14425
COSCO SHIPPING Ports Announces 2026 Interim Results
Weaving New Connections Empowering Smart Journeys HONG KONG, Aug. 28, 2026 /PRNewswire/ -- COSCO SHIPPING Ports Limited ("COSCO SHIPPING Ports" or "CSP" or the "Company", SEHK: 1199), the world's leading ports logistics service provider, today announced the interim results of the Company and its...
2026-08-28 22:02
5241
Syria marks first international card transaction in more than 15 years with Mastercard and QNB Group
* The transaction follows the reconnection of the country's payments ecosystem to Mastercard's global network * The first payment paves the way for international card acceptance in Syria DAMASCUS, Syria, Aug. 28, 2026 /PRNewswire/ -- Mastercard and QNB Group have processed Syria's first inter...
2026-08-28 21:48
3120
SuperX Secures First Batch of 128 Units of NVIDIA B300 AI Server Purchase Order from Ezisight, Marking Its Official Entry into the Australian Market
SINGAPORE, Aug. 28, 2026 /PRNewswire/ -- SuperX AI Technology Limited (NASDAQ: SUPX, "SuperX" or the "Company"), a Nasdaq‑listed full‑stack AI infrastructure solutions provider, today announced that its subsidiary SuperX Microinference Pte Ltd ("Microinference") has signed an equipment and servic...
2026-08-28 21:44
7196
Fireblocks Sets Sights on Next Phase of Tokenization: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 28, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...
2026-08-28 21:19
4496
SuperX Secures First Batch of 128 Units of NVIDIA B300 AI Server Purchase Order from Ezisight, Marking Its Official Entry into the Australian Market
SINGAPORE, Aug. 28, 2026 /PRNewswire/ -- SuperX AI Technology Limited (NASDAQ: SUPX, "SuperX" or the "Company"), a Nasdaq‑listed full‑stack AI infrastructure solutions provider, today announced that its subsidiary SuperX Microinference Pte Ltd ("Microinference") has signed an equipment and servic...
2026-08-28 21:18
4641
Global Tier-1 YFORE Rolls Off First U.S.-Built Digital Key
SUWANEE, Ga., Aug. 28, 2026 /PRNewswire/ -- YFORE Technology officially rolled off its first U.S.-manufactured Digital Key today at its facility in Suwanee, Georgia, marking the start of localized mass production for North America. Utilizing an integrated "Vehicle-Cloud-Device" end-to-end archite...
2026-08-28 21:15
2796
Tineco Brings Next-Generation Floor Care Innovations at IFA 2026
"The Future Cleans Itself" takes the centre stage as Tineco showcases its
latest innovations in smart floor care at IFA 2026
SEATTLE, Aug. 28, 2026 /PRNewswire/ -- Tineco
2026-08-28 21:00
3274
SmallRig Technology Announces Completion of Acquisition of Selected Assets of Kelvin Group
SHENZHEN, China and OSLO, Norway, Aug. 28, 2026 /PRNewswire/ -- SmallRig Technology (HK) Limited ("SmallRig Technology") today announced the successful completion of its acquisition of selected assets relating to Kelvin Group AS (" Kelvin Group"). The acquired assets include, among others, the Kel...
2026-08-28 21:00
3640
Luxshare Precision Expects Net Profit to Rise 15%-25% in the First Nine Months of 2026
Growth outlook supported by continued execution across consumer electronics, AI data center infrastructure and automotive electronics DONGGUAN, China, Aug. 28, 2026 /PRNewswire/ -- Luxshare Precision Industry Co., Ltd. ("Luxshare Precision" or the "Company") (SZSE: 002475; HKEX: 02475), a global...
2026-08-28 21:00
4772
KLN Delivers Sustained Growth in Revenue and Core Net Profit
HONG KONG, Aug. 28, 2026 /PRNewswire/ -- KLN Logistics Group Limited ('KLN' or together with its subsidiaries, the 'Group'; Stock Code 0636.HK) today announced the Group's interim results for the six months ended 30 June 2026. Group's Financial Highlights and Dividend * Revenue grew by 10% yea...
2026-08-28 20:52
3682
Leifras Celebrates 25th Anniversary, Setting Vision for Becoming Global Infrastructure Through "Sports and Social"
Operating Across All 47 Prefectures in Japan, Ranking No. 1 in School Club Activity Support (According to Tokyo Shoko Research, as of December 2025) with Over 70,000 Sports School Members. Following Its Nasdaq Listing, Leifras Sets Vision for the Next 25 Years to Establish Sustainable Education, ...
2026-08-28 20:30
4677
Ulike Brings "Future Beauty, Powered by Light" to Boston, Challenging the Conventional Beauty Trade-Off Between Efficacy and Comfort
Nobel Prize-winning scientist Dr. Ardem Patapoutian, Harvard Associate Professor Dr. Anna Mandinova, actress, wellnessadvocate, and entrepreneur Sasha Pieterse, and PCOSAA CEO Megan Stewart joined Ulike to redefine the standard of beauty. BOSTON, Aug. 28, 2026 /PRNewswire/ -- Ulike, a global bea...
2026-08-28 20:30
3548
GeeLark Expands Its AIGC Suite and Opens AI Content Creation to Free Users
SINGAPORE, Aug. 28, 2026 /PRNewswire/ -- GeeLark today announced a major
expansion of its AIGC capabilities, introducing new AI models and editing tools
for social media content creation. Previously available only to paid users,
GeeLark AIGC can now also be used on the free plan.
2026-08-28 20:15
2826
Formosa Pharmaceuticals Files Clinical Trial Application for TSY-110, an Antibody-Drug Conjugate Biosimilar Targeting HER2-Positive Breast Cancers
TSY-110 is positioned to become the first biosimilar alternative to Roche's Kadcyla® (ado-trastuzumab emtansine) in major regulated markets. TAIPEI, Aug. 28, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (TWSE: 6838), today announced the submission of a Clinical Trial Application (CTA) to E...
2026-08-28 20:03
2579
HiRO and Differentia Biotech Forge Strategic Alliance to Redefine Clinical Trial Design Through AI-Powered Simulation
* Memorandum of Understanding establishes a framework for joint development of clinical trial simulation capabilities * The partnership unites global clinical operations excellence with advanced digital twin technology, delivering simulation-first drug development to biotech sponsors navigati...
2026-08-28 20:00
2192
Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma
SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion for its core products, the company is accelerating...
2026-08-28 19:31
3310
Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering
SYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced the ...
2026-08-28 19:30
3542
Why Helsinki Should Be on Every Art Lover's Travel List in Summer 2027
HELSINKI, Aug. 28, 2026 /PRNewswire/ -- Following a record-breaking edition that attracted more than half a million visits, Helsinki Biennial returns in summer 2027, inviting visitors to discover world-class contemporary art across the historic island of Vallisaari, Esplanade park and HAM Helsink...
2026-08-28 19:09
2049
InxMed Announces Publication in The Lancet Oncology Featuring Encouraging Antitumor Activity of Ifebemtinib in Combination with Garsorasib in Previously Treated Metastatic Colorectal Cancer (CRC) Harboring KRAS G12C Mutation
NANJING, China, Aug. 28, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and metastasis, today announced that the clinical results of ifebemtinib (IN10018), a highly selectiv...
2026-08-28 19:00
2709
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1183 media titles]
2026-11-13 22:11
Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1170 media titles]
2026-11-12 23:00
The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1168 media titles]
2026-11-14 13:23
Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00Most Read
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
2026-11-13 13:00
132904
Royal Bank of Canada announces agreement to acquire Yarra Capital Management
2026-11-09 21:00
10484
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
2026-11-09 23:00
9713
Poppi Founders Launch Hydration Brand jetty: NYSE Content Update
2026-11-10 22:17
8197
